DexCom (NASDAQ: DXCM) reported Q2 EPS of $0.48, $0.03 better than the analyst estimate of $0.45. Revenue for the quarter came in at $1.16 billion versus the consensus estimate of $1.12 billion.

GUIDANCE:

DexCom sees FY2025 revenue of $4.6-4.625 billion, versus the consensus of $4.611 billion.

For earnings history and earnings-related data on DexCom (DXCM) click here.